Volume 5, Issue 4 (3-2023)                   2023, 5(4): 0-0 | Back to browse issues page

Ethics code: IR.MEDILAM.REC.1400.124

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mendeley  
Zotero  
RefWorks

Tardeh S, Adibi A, Mozafari A A. Study the Prevalence of Suicidal Ideation and Suicidal Attempt during the COVID-19 pandemic: A Systematic Review and Meta-Analysis Study. Journal title 2023; 5 (4)
URL: http://newresearch.medilam.ac.ir/article-1-1530-en.html
Medical University
Abstract:   (1012 Views)
Corona Virus 2019 (COVID-19) is a new infectious disease that emerged in late 2019 in Wuhan, China and spread rapidly around the world. The COVID-19 epidemic is seriously affecting the daily lives of people around the world, including their health, economic well-being and social interactions. An epidemic of infectious diseases, as a major stressors in the lives of people and people around, can have many effects on mental health. Unpredictability and uncertainty about the COVID-19 pandemic, fear of infection and COVID-19-related environmental changes are the main stressors that cause mental health problems. And some factors, including economic hardship, social support, increased stress, and unemployment, may be associated with suicidal behaviors.

Suicidal behaviors are multifactorial and involve complex interactions between biological and environmental factors. Among them, a major risk factor for suicidal ideation is a stressful life. Preliminary reports of a suicide wave have been reported in several studies at different stages of the epidemic
As a severe crisis, suicidal ideation and related factors in the general population must be systematically examined.
     

Received: 2021/06/25 | Accepted: 2021/09/15 | Published: 2023/03/1

Add your comments about this proposal : Your username or Email:
CAPTCHA

Send email to the proposal executer


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.